Inmunoterapia en epilepsia refractaria

- Aikoh H, Sasaki M, Sugai K, Yoshida H, Sakuragawa N. Case Report: Effective immunoglobulin therapy for brief tonic seizures in Methylmalonic acidemia. Brain & Development 1997; 19: 502-505.

- Best CH, Taylor. El Sistema de Control Hipotálamo

- hipofisiario. En: Bases fisiológicas de la Práctica Médica, cap. 52, 11ª edición. West JB. ed. Baltimore Williams and Wilkins, 1986: 1031- 1044.

- Billiau A, Witters P, Ceulemans B, Kasran A, Wouters C, Lagae L. Intravenous Immunoglobulins in Refractory Childhood-onset Epilepsy: Effects on Seizure Frequency, EEG Activity, and Cerebrospinal Fluid Cytokine Profile. Epilepsia 2007; 48:1739-1749.

- Feasby T, Banwell B, Benstead T, et al. Guidelines on the Use of Intravenous Immune Globulin for Neurologic Conditions. Transfusion Medicine Reviews 2007; 21 Suppl 1: pp S57-S107.

- Gallagher S, Weiss S, Oram Cardy J, Humphries T, Harman K, Menascu S. Efficacy of very high dose steroid treatment in a case of Landau-Kleffner Syndrome. Developmental Medicine & Child Neurology 2006; 48: 766-769.

- Granata T, Fusco L, Gobbi G, et al. Experience With Immunomodulatory Treatments In Rasmussen’s Encephalitis. Neurology 2003; 61:1807-1810.

- Gupta R, Appleton R. Corticosteroids Inin Thethe Management Ofof Thethe Paediatric Epilepsies. Arch Dis Child 2005;90: 379-384.

- Kivito S, Lerman R, Ariel R, Danziger Y, Mimouni M, Shinnar S. Long-Term Cognitive Outcomes of a Cohort of Children Withwith Cryptogenic Infantile Spasms Treated with High Dose of Adrenocorticotrophic Hormone. Epilepsia 2004; 45: 255-262.

- Mackay M, S, Weiss S, Adams-Webber T, et al. Medical Treatment of Infantile Spasms Report of the American Academy of Neurology and the Child Neurology Society. Neurologyy 2004; 62:1668-1681.

- McKnight K, Jiang Y, Hart Y et al. Serum Antibodies in Epilepsy and Seizure-Associated Disorders. Neurology, 2005; 65:1730-1736.

- Medina Malo, C; Arango, G; Carreño, O; Uscátegui, A. Etiología de la Epilepsia. En: Epilepsia: Aspectos Clínicos y Psicosociales. C. Medina Malo, ed. Bogotá: Editorial Médica Panamericana, 2004: 90-109.

- Oguni, H, Funatsuka M, Sasaki K et al. Effect of ACTH Therapy for Epileptic Spasms without Hipsarritmia. Epilepsia 2005; 46:709-715.

- Oguni H, Yanagaki S, Hayashi K et al. extremely low-dose ACTH step-up protocol for West syndrome: Maximum therapeutic effect with minimal side effects. Brain & Development 2006; 28: 8-13.

- Riikonen, R.S. Steroids or Vigabatrin in the Treatment of Infantile Spasms? Pediatr Neurol 2000; 23:403-408.

- Roubertie A, Boukhaddaoui H, Sieso V et al. Antiglial Cell Autoantibodies and Childhood Epilepsy: A Case Report. Epilepsia 2005; 46:1308-1312.

- Shinoda S, Skradski S, Araki T et al. Formation Of A Tumor Necrosis Factor Receptor 1 Molecular Scaffolding Complex And Activation Of Apoptosis Signal-Regulating Kinase 1 During Seizure-Induced Neuronal Death. European Journal of Neuroscience 2003; 17: 2065-2076

- Sinclair D B. Prednisone therapy in pediatric epilepsy. Pediatr Neurol 2003; 28: 194-198.

- Takahashi Y, Mori H, Mishina M et al. Autoantibodies and Cell-mediated Autoimmunity to NMDA-type GluR?2 in Patients with Rasmussen’s Encephalitis and Chronic Progressive Epilepsia Partialis Continua. Epilepsia 2005; 46(Suppl. 5):152-158.

- Verhelst H, Boon P, Buyse G et al. Steroids in intractable childhood epilepsy: Clinical experience and review of the literature. Seizure 2005; 14: 412 - 421.

- Vezzani A, Granata T. Brain Inflammation in Epilepsy: Experimental and Clinical Evidence. Epilepsia 2005; 46):1724-1743.

- Villani F, Avanzini G. The Use of Immunoglobulins in the Treatment of Human Epilepsy. Neurol Sci 2002;

:S33-S37.